Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Succinylcholine Chloride Dihydrate

    • Product Name Succinylcholine Chloride Dihydrate
    • Alias SUX
    • Einecs 242-015-4
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    342673

    Chemical Name Succinylcholine Chloride Dihydrate
    Molecular Formula C14H30Cl2N2O4·2H2O
    Molecular Weight 442.35 g/mol
    Cas Number 6101-15-1
    Appearance White crystalline powder
    Solubility Freely soluble in water
    Storage Temperature 2-8°C
    Synonyms Suxamethonium Chloride Dihydrate
    Pharmacological Class Depolarizing neuromuscular blocker
    Ph Range In Solution 3.0 - 4.5
    Stability Stable under recommended storage conditions
    Usage Used as a skeletal muscle relaxant in anesthesia

    As an accredited Succinylcholine Chloride Dihydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging contains 25 grams of Succinylcholine Chloride Dihydrate, sealed in a labeled, tamper-evident amber glass bottle with hazard warnings.
    Shipping Succinylcholine Chloride Dihydrate is shipped as a hazardous chemical under controlled conditions. It should be packed in tightly sealed containers, protected from moisture and light, and transported with temperature regulation if required. Proper labeling, documentation, and adherence to relevant regulations for toxic and controlled substances are mandatory during shipping.
    Storage Succinylcholine Chloride Dihydrate should be stored in a tightly sealed container, protected from light and moisture. Store at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). Avoid exposure to extreme heat or freezing. Keep away from incompatible substances and ensure storage in a secure, well-ventilated area, accessible only to authorized personnel.
    Application of Succinylcholine Chloride Dihydrate

    Applications of Succinylcholine Chloride Dihydrate in Industrial Manufacturing

    Succinylcholine Chloride Dihydrate serves key functions in advanced industrial processes, with primary use concentrated within controlled medical, pharmaceutical, and clinical environments. From injectables to diagnostic kits, its downstream integration requires strict adherence to safety, formulation, and regulatory frameworks. Below, we outline principal sectors where this material finds validated, compliant use.

    1. Injectable Muscle Relaxant Formulations for General Anesthesia

    Hospitals and licensed pharmaceutical manufacturers rely on this compound as an active ingredient for producing parenteral neuromuscular blocking agents. It serves as a rapid-onset muscle relaxant, commonly utilized to facilitate tracheal intubation and short procedures under general anesthesia. The formulation process includes sterile compounding, precise pH adjustment, and endotoxin control, with batch records tied to each production lot. Only facilities certified in aseptic filling and parametric release can integrate this raw material, ensuring traceability from synthesis to final packaging.

    Industry compliance standards

    • United States Pharmacopeia (USP) Monograph for Succinylcholine Chloride; USP Chapter <797> Sterile Compounding Standards
    • European Pharmacopoeia (Ph. Eur.) requirements for active pharmaceutical ingredients
    • Good Manufacturing Practice (GMP) compliance: ICH Q7, FDA 21 CFR Parts 210/211
    • Certificate of Suitability (CEP) for API usage

    Typical usage ratio

    • 2–10 mg/mL in intravenous solution formulations, adjusted according to drug product specification and clinical dose requirements

    Downstream process integration

    • Added during bulk compounding under a laminar flow hood
    • Mixed with sterile excipient solutions and stabilizers
    • Final solution filters through 0.22 micron before aseptic filling
    • Sealed into glass ampoules or vials, terminally sterilized if required by protocol

    Final product types

    • Injectable ampoules and vials supplied to surgical suites and critical care facilities
    • Ready-to-use emergency neuromuscular blockade kits for medical centers

    2. API Source for Generic Parenteral Drug Manufacturing

    Bulk pharmaceutical manufacturers use this material as the core API for registering and producing generic injectable muscle relaxants after the expiration of original product patents. Maintaining uniformity, impurity profiles, and reproducibility is critical for regulatory approval and market access. Analytical labs perform validation of each incoming lot by HPLC and compendial testing before release to production tanks. Regulatory dossiers must demonstrate source GMP traceability and stable supply agreements for commercial scale.

    Industry compliance standards

    • Active Substance Master File (ASMF) registration (EU/EMA)
    • Drug Master File (DMF) submission (US FDA)
    • WHO GMP prequalification (for global tenders/UN supply)
    • ICH Q3A/B (Impurities in APIs/Drug Products)

    Typical usage ratio

    • In accordance with finished product dossiers: 100% of labeled API content, typically 2–20 mg/mL depending on concentration and dosage form

    Downstream process integration

    • Direct charge to formulation reactors after quality control sampling
    • Blending with excipients and adjuncts for solution clarity and chemical stability
    • In-process controls for pH, endotoxins, and peptide sequence verification

    Final product types

    • Generic succinylcholine chloride injectable solutions distributed via hospitals and pharmacy wholesalers
    • Multinational market-packaged muscle relaxant products registered for regulated and semi-regulated countries

    3. Biochemical Research and Laboratory Diagnostic Reagents

    Research reagent companies purchase pharmaceutical-grade succinylcholine chloride for muscle tissue contractility assays, electrophysiology studies, and cell signaling investigations. Laboratory technicians must ensure batch quality for reproducibility across experiments in neurobiology and biosignal research. Distribution occurs in pre-weighted ampoules or lyophilized aliquots, depending on intended applications. Custom concentrations or salt forms may be specified for high-throughput screening systems or in vitro study protocols.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems for laboratory reagent production
    • Certifications of Analysis (COA) for each shipped lot
    • Traceable chain-of-custody documentation for research-grade chemicals
    • Material Safety Data Sheets (MSDS)/Globally Harmonized System (GHS) compliance

    Typical usage ratio

    • 5–500 µM in physiological buffer for ex vivo tissue or cellular studies; precise levels determined by experimental protocol and model species

    Downstream process integration

    • Weighing and dissolution into research-grade solvents in clean room facilities
    • Aliquoting into sterile reaction vials for end-user handling
    • Custom packaging based on customer assay workflow (powder, solution, kit)

    Final product types

    • Biochemical assay kits for muscle and nerve tissue pharmacodynamics
    • Standard reference materials for contract research organizations (CROs) and university labs

    4. Training and Quality Control Simulant Solutions for Hospital Equipment Validation

    Medical device companies and hospital pharmacists prepare training and calibration solutions using this material to validate neuromuscular monitoring systems and anesthesia delivery devices. These solutions do not enter clinical use in patients but provide a controlled medium for protocol rehearsal, device QC, and simulation-based staff certification. Formulation accuracy directly influences calibration curves and device reliability checks. Preparation must follow traceability requirements for critical equipment QC.

    Industry compliance standards

    • ISO 13485:2016 Medical Devices — Quality Management Systems
    • Joint Commission (JCI) and national hospital accreditation regulations (e.g., US CMS Conditions of Participation)
    • Local controlled substance handling and waste disposal laws

    Typical usage ratio

    • 0.1–5 mg/mL in isotonic saline solution; adjusted to align with equipment manufacturer’s test protocols for calibration accuracy

    Downstream process integration

    • Formulated in controlled non-clinical laboratory environments
    • Dispensed into single-use validation units for device QC teams
    • Documentation maintained for equipment certification records

    Final product types

    • Calibration and validation kits for hospital anesthesia and neuromuscular monitors
    • Simulation training packs for hospital-based medical staff certification programs
    Free Quote

    Competitive Succinylcholine Chloride Dihydrate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Succinylcholine Chloride Dihydrate: Reliable Performance from a Manufacturer’s Bench

    What Our Experience Tells Us About Succinylcholine Chloride Dihydrate

    Succinylcholine Chloride Dihydrate sits among the most closely scrutinized molecules in the pharmaceutical industry. Our production lines for this compound operate under a steady hum of purpose and vigilance. Succinylcholine Chloride Dihydrate finds its place in operating theaters and clinical settings, bringing precise and temporary muscle relaxation that makes certain medical procedures possible. Every batch must respect the strictest tolerances because its users—anesthesiologists, surgeons, critical care teams—cannot afford slips in quality.

    What sets this compound apart for us as a manufacturer is the attention it demands from the very first step of synthesis. We source our raw inputs directly—no shortcuts, no substitutions. Each stage, from the preparation of succinic acid derivatives through to the final hydration and crystallization, invites its own checks. Our teams focus on forming a product that presents consistent bulk density, stable moisture content, and a reproducible crystalline form. This careful craftsmanship does more than hit regulatory targets; it pays respect to the needs of the people who rely on us.

    Understanding Model and Specifications from a Production View

    We supply Succinylcholine Chloride Dihydrate as fine, flowable crystalline powder. The most common model in our facility comes in bulk packaging suitable for compounding and pharmaceutical manufacturing needs, measured by precise weight and purity. The dihydrate form, as opposed to the anhydrous variant, delivers a level of chemical stability that manufacturers find essential for extended storage and smooth blending in downstream processes.

    Our analytical chemists run rigorous assays using titration and HPLC analysis to verify composition. Purity consistently reaches 99% or greater, and we never see batch-to-batch swings in labeling water of hydration. Particle size distribution lands in a range that supports accurate weighing and dispersion, since clumping poses unacceptable risks in pharmaceutical compounding. We use absence of heavy metals, low endotoxin levels, and confirmed chemical identity by NMR and IR spectroscopy as daily benchmarks. Whenever a lot goes through testing, both internal teams and third-party labs verify these benchmarks. Succinylcholine Chloride Dihydrate does not forgive shortcuts.

    Usage Insights from a Manufacturer’s Lens

    Experience on our production floor feeds directly into quality pharmaceutical outcomes. Succinylcholine Chloride Dihydrate enters the anesthesiology world not as a monograph in a book, but as a life-essential tool. It comes to life in the hands of compounding pharmacists, who trust nothing but the most consistent batches during the preparation of injectable forms. They expect powder that reconstitutes cleanly, dissolves swiftly, and maintains solution clarity. For that, we make sure ionic content and micro-particulate levels fall within tight bands. Any deviation would echo in the product’s clinical behavior.

    The powder’s ready solubility, owed to its dihydrate state, provides even dispersion in aqueous vehicles. Our staff maintains rigid control over trace element content, because presence of even minute residuals can trigger unacceptable patient reactions. The strong acetylcholine-mimetic mechanism of the drug means only a flawless substrate can support safe use. Handling procedures at our facilities follow strict protocols—operators work in controlled environments with specialized training, using protective gear and validated handling equipment to eliminate contamination risks.

    Key Differences Observed Beside Other Neuromuscular Blocking Agents

    During decades of producing neuromuscular drug ingredients, distinctions between Succinylcholine Chloride Dihydrate and other muscle relaxant compounds have stood out. Succinylcholine’s rapid onset results from its direct, depolarizing action at the neuromuscular junction. This is not a quaternary ammonium compound with intermediate or long duration effects like pancuronium or vecuronium. Its two acetylcholine-like ends occupy receptors, then hydrolyze swiftly under plasma cholinesterase activity, leaving behind a fleeting blockade.

    Our teams notice, year after year, that the dihydrate crystal form resists humidity-driven clumping better than the anhydrous forms of other skeletal muscle relaxants. This trait makes it a natural fit for large-scale pharmaceutical processing where consistent powder flow is a must. Many non-depolarizing alternatives require more complex packaging and storage conditions—Succinylcholine, in its most stable dihydrate form, supports facilities that may not feature advanced climate controls.

    From the production side, maintaining the integrity of the dihydrate means controlling relative humidity throughout synthesis, drying, and packaging. Over-drying risks breaking the hydrate bonds, shifting the material’s solubility and dissolution time. Under-drying encourages aggregates that frustrate automated feeding equipment. Our operators track temperature and airflow in real time, logging every movement to keep the specification stable.

    Compared to formulations built from other neuromuscular drugs—cisatracurium besylate, rocuronium bromide, atracurium—the dihydrate’s shelf stability impresses. Where some powders may yellow or cake after months in finished goods storage, our well-packaged Succinylcholine Chloride Dihydrate preserves its white, crystalline appearance without odor or loss of activity.

    Tackling the Challenges of Manufacturing Active Neuromuscular Compounds

    Safety sits front and center each day as Succinylcholine Chloride Dihydrate comes off our lines. The molecule’s extreme potency demands more from the manufacturing side than many standard pharmaceutical ingredients. Operators manage tightly sealed vessels and double-walled transfer valves. Any spill or dust release requires immediate remediation using specialized absorbents and personal protective equipment designed for potent agent processing. Our incident logs show few events, but each one triggers an incident review and process improvement.

    Maintaining GMP-compliant suites at all stages of production, storage, and transport is non-negotiable. Temperature and humidity logs run without gaps. Operators rotate across roles, updating skills annually with scenario-based safety drills. Environmental monitoring—surface swabs, airborne particle counts, microbiological sampling—runs twice every shift. Documentation for each batch, from raw input receipts to final product release, fills entire floor-to-ceiling cabinets in our quality control offices.

    Analytical verification and batch-release protocols lean on advanced instrumentation. Mass spectrometry, proton NMR, FTIR, and liquid chromatography isolate signals that guarantee every shipment meets the declared specification for both chemical content and hydration state. Regular inspections from both national and international regulatory agencies keep procedures sharp and staff responsive.

    From Lab Bench to Global Health Systems

    As a manufacturer, we see the real-world weight that each batch carries. Succinylcholine Chloride Dihydrate’s primary application lands in rapid-sequence induction and emergency airway management. The compound’s role in facilitating intubation—quick, short-acting paralysis—has saved untold numbers of lives. Our reputation rides on strong, steady supply to national health systems, major hospitals, and specialist clinics.

    Annual demand fluctuations keep our inventory departments on careful watch. Pandemic emergencies, natural disasters, and the swings of elective procedure volumes all leave their mark on order books. We plan batch sizes and procurement cycles months ahead, making use of industry data and close communication with regulatory authorities. Each kilogram of finished powder triggers a cascade—shipping schedules, cold-chain assessments for certain destinations, and delivery verification on arrival.

    In the face of global shortages, our commitment means accelerating throughput where possible while never crossing the line on GMP compliance or material quality. Raw input reserves run deep, and second-source supply chains are always tested and validated, never assumed. Shipment documentation gives full traceability, letting end users see exactly where their product originated and how it moved.

    Why the Dihydrate Form Shapes Downstream Quality

    Pharmaceutical manufacturers often ask our technical support teams why we favor the dihydrate form over anhydrous or alternative salts. The answer grows from our own in-process experience. The dihydrate state balances water content and chemical stability, reducing hydrolysis and degradation risks during both processing and storage. Finished pharmaceuticals built from our material show consistently reliable reconstitution times and improved control over the final dosage form.

    Aqueous solutions prepared from our Succinylcholine batches never turn turbid, so long as storage and handling follow well-established protocols. This attribute reflects our tight control over both contaminant levels and hydrate integrity during drying and post-synthesis handling. Pharmaceutical firms return for resupply above all due to batch-to-batch reproducibility—a direct outgrowth of hands-on process validation rather than formula alone.

    Supporting Quality at End-User Level

    After years shipping Succinylcholine Chloride Dihydrate to formulators worldwide, common feedback centers on predictability—our powder dissolves and dilutes as expected, even during high-pressure compounding at emergency facilities. Powder color, crystal size, and flow characteristics fall within narrow bands, reducing incidents of mismeasurement or repackaging error at the compounding stage.

    End users—pharmacists, formulation scientists, and procurement teams—look for certificates of analysis that actually match in-house test results. Our documentation includes every relevant parameter, signed off by technical experts intimately acquainted with the underlying chemistry. Quality audits rarely flag discrepancies, a result driven by the investment in skilled personnel and modern equipment at every node of the process.

    We field technical questions from both new and long-standing customers: best storage recommendations, in-use time after reconstitution, and recognized incompatibilities in compounded admixtures. Years of feedback from the clinical field return to us as process improvements: where fine dust carries from an open container, we transition to new anti-static linings; where needle clogging occurs, we refine sieving during final milling. Each improvement springs from practical experience and direct user reports, not mere theoretical considerations.

    Product Reliability and Our Place in Pharmaceutical Supply Chains

    We recognize Succinylcholine Chloride Dihydrate as more than a chemical—its routine, invisible presence in hospital stocks reflects broad trust in our production capabilities. Interruptions in supply or unexpected defects do not just disrupt business, they risk outcomes in intensive care units and operating theaters.

    Coordination between production, analytical, storage, logistics, and regulatory compliance teams reduces risk along the supply chain. Packaging incorporates multi-layer barriers to block moisture ingress; labeling ensures users never mistake lot numbers or expiry dates. Each outgoing batch leaves with documented proof of sterility, heavy metal compliance, and chain of custody, right up to the delivery door.

    Global health regulations evolve, driving us to upgrade systems for allergens, residual solvents, and traceability every year. Our engineers introduce in-line monitoring tools and network our plant databases to keep every team updated in real time. Root cause analysis follows any reported deviation, feeding back into training and process standards. We treat every feedback point—internal or external—as a lever for stronger final outcomes, not simply a metric to tick off an audit checklist.

    Raising the Bar: Quality Beyond Compliance

    Producing active compounds like Succinylcholine Chloride Dihydrate reveals the shortfall of settling merely for regulatory compliance. We see this every time regulatory standards tighten: labs with less robust systems scramble to adapt, while our technical team already tracks those stricter benchmarks through in-house programs. Investments in validated HVAC, automated monitoring, and strict inventory management deliver results that don’t just pass but consistently exceed requirements.

    We partner with major pharmaceutical developers and government agencies, sharing data and collaborating on advance notice of market surges or potential disruption. These relationships give us early signals to scale batches, plan preventive maintenance, and avoid overpromising during high-stress procurement periods. Our people occupy a unique vantage: one foot in science, one in operations, all directed at practical supply security.

    Every improvement bridges the needs of today’s patient outcomes with the expectations of tomorrow’s regulatory and professional landscapes. Long before any crisis appears on the front pages, our laboratories and warehouses have run drills for surge capacities, product recalls, and multi-site distribution. Strengthening staff, processes, and global relationships forms the heartbeat behind every shipment—especially on those products, like Succinylcholine Chloride Dihydrate, whose role in care is both immediate and profound.

    Looking Ahead: Solutions for Enduring Supply and Advanced Quality

    Long-term reliability for hospital and health system partners depends on unbroken supply and repeatable product properties. We invest in buffer stock at regional distribution centers, not just at the main production location, to guarantee rapid turnaround during medical emergencies or national shortages. We watch industry trends closely; even subtle regulatory shifts in allowable impurity profiles or new pharmacopoeia monographs push our process teams to revalidate methods and tighten specifications.

    Supplier partnerships matter as much as in-house discipline. Qualified, trusted sources for succinic acid, choline derivatives, and pharmaceutical-grade sodium chloride sustain consistency from the ground up. Whenever a raw input shows unwanted variance, we act fast, rerouting production or qualifying substitute lots only once they exceed internal screening. This upstream focus on input quality offers insurance against unforeseen shocks, helping downstream users avoid last-minute switching or product recalls.

    Technological advances in crystallization, filtration, and automatic dispensing equip our next expansion efforts. These allow further reductions in particulate content, tighter humidity tolerances, and more uniform packaging. We see the challenge not as producing Succinylcholine Chloride Dihydrate “good enough to pass,” but rather as a matter of ongoing stewardship of a vital healthcare resource. Solutions begin on our side—process discipline, continuous technological upgrades, strong supplier relationships—and finish in the safe and effective hands of clinical professionals worldwide.

    The Spirit Behind Manufacturing Succinylcholine Chloride Dihydrate

    Years of experience with this product teach us that reliability grows from everyday dedication. Teams across our company—chemists, engineers, packagers, logistics specialists—share ownership in every batch. No single role makes all the difference, but every role counts. We do not see Succinylcholine Chloride Dihydrate as a simple “item” moving from shelf to truck; we see it as the distillation of thousands of small, careful actions, converging to support frontline healthcare when it matters most.

    Each batch reflects the expertise and commitment of the people behind it, honed over countless cycles of testing and improvement. Our approach to manufacturing rests on the knowledge that lives depend on consistency, safety, and quality. We carry these values forward in every order, every process upgrade, and every innovation—so Succinylcholine Chloride Dihydrate reaches those who need it most, meeting their expectations every time.